TABLE 1.
Ox. STa | No. of isolates | No. of wardsb | Isolation date | % of resistant isolates resistant against the following antibioticc: |
|||||
---|---|---|---|---|---|---|---|---|---|
AMK | CTX | CEP | LVX | IPM | MEM | ||||
136 | 7 | 4 | 2016, 2017 | 100 | 100 | 42.9 | 100 | 85.7 | 100 |
208 | 23 | 8 | 2007, 2008, 2011, 2016 | 95.7 | 100 | 73.9 | 95.7 | 87 | 91.3 |
369 | 5 | 4 | 2011, 2016 | 100 | 100 | 80 | 100 | 100 | 100 |
417 | 38 | 7 | 2008, 2009, 2010 | 100 | 97.4 | 97.4 | 100 | 100 | 100 |
Ox. ST, sequence type by the Oxford MLST scheme.
Number of different wards in which the isolates were sampled.
Percentage of isolates resistant against different antibiotics. The antibiotics tested were amikacin (AMK), cefotaxime (CTX), cefepime (CEP), levofloxacin (LVX), imipenem (IPM), meropenem (MEM), gentamicin, and tetracycline. All the isolates were 100% resistant against gentamicin and tetracycline.